LivaNova (LIVN) Competitors $46.13 +0.05 (+0.11%) Closing price 01:00 PM EasternExtended Trading$46.10 -0.03 (-0.07%) As of 04:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LIVN vs. PEN, STVN, GKOS, IRTC, NARI, TMDX, BLCO, SLNO, INSP, and NVSTShould you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), iRhythm Technologies (IRTC), Inari Medical (NARI), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), and Envista (NVST). These companies are all part of the "medical equipment" industry. LivaNova vs. Its Competitors Penumbra Stevanato Group Glaukos iRhythm Technologies Inari Medical TransMedics Group Bausch + Lomb Soleno Therapeutics Inspire Medical Systems Envista Penumbra (NYSE:PEN) and LivaNova (NASDAQ:LIVN) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends. Do institutionals & insiders hold more shares of PEN or LIVN? 88.9% of Penumbra shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 4.2% of Penumbra shares are held by company insiders. Comparatively, 0.3% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is PEN or LIVN more profitable? Penumbra has a net margin of 3.41% compared to LivaNova's net margin of -17.41%. LivaNova's return on equity of 13.67% beat Penumbra's return on equity.Company Net Margins Return on Equity Return on Assets Penumbra3.41% 11.14% 8.40% LivaNova -17.41%13.67%6.68% Which has more risk & volatility, PEN or LIVN? Penumbra has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500. Comparatively, LivaNova has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500. Do analysts rate PEN or LIVN? Penumbra currently has a consensus target price of $302.40, suggesting a potential upside of 20.70%. LivaNova has a consensus target price of $59.29, suggesting a potential upside of 28.52%. Given LivaNova's stronger consensus rating and higher possible upside, analysts clearly believe LivaNova is more favorable than Penumbra.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Penumbra 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.88LivaNova 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has better valuation and earnings, PEN or LIVN? LivaNova has higher revenue and earnings than Penumbra. LivaNova is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPenumbra$1.19B8.12$14.01M$1.06236.36LivaNova$1.25B2.01$63.23M-$4.09-11.28 Does the media favor PEN or LIVN? In the previous week, Penumbra had 17 more articles in the media than LivaNova. MarketBeat recorded 17 mentions for Penumbra and 0 mentions for LivaNova. Penumbra's average media sentiment score of 1.06 beat LivaNova's score of 0.00 indicating that Penumbra is being referred to more favorably in the media. Company Overall Sentiment Penumbra Positive LivaNova Neutral SummaryPenumbra beats LivaNova on 9 of the 16 factors compared between the two stocks. Get LivaNova News Delivered to You Automatically Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LIVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LIVN vs. The Competition Export to ExcelMetricLivaNovaMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.51B$6.92B$5.54B$8.95BDividend YieldN/A1.23%5.38%4.08%P/E Ratio-11.2826.6327.4020.04Price / Sales2.0199.70419.46118.60Price / Cash10.8720.9736.6357.47Price / Book1.904.748.085.67Net Income$63.23M$173.18M$3.16B$248.47M7 Day Performance0.72%1.52%2.12%2.90%1 Month Performance4.60%0.14%4.43%5.75%1 Year Performance-12.62%28.37%35.62%21.36% LivaNova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LIVNLivaNova2.4974 of 5 stars$46.13+0.1%$59.29+28.5%-12.9%$2.51B$1.25B-11.282,900PENPenumbra4.7342 of 5 stars$256.00-0.2%$302.40+18.1%+41.8%$9.93B$1.19B77.944,500Positive NewsInsider TradeSTVNStevanato Group1.0554 of 5 stars€24.51-0.5%N/A+36.2%€7.42B€1.19B48.065,521Positive NewsAnalyst ForecastGap DownGKOSGlaukos4.4477 of 5 stars$103.42+2.0%$134.67+30.2%-12.8%$5.80B$383.48M0.00780IRTCiRhythm Technologies1.2147 of 5 stars$153.96-0.5%$138.60-10.0%+44.8%$4.94B$591.84M0.002,000Insider TradeNARIInari Medical0.5358 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800TMDXTransMedics Group1.6051 of 5 stars$134.01+1.9%$127.33-5.0%-14.3%$4.45B$441.54M96.65210Positive NewsBLCOBausch + Lomb3.3959 of 5 stars$13.03+5.1%$15.54+19.3%-6.2%$4.39B$4.79B25.8313,500High Trading VolumeSLNOSoleno Therapeutics4.2136 of 5 stars$83.78+0.6%$107.10+27.8%+117.0%$4.20BN/A0.0030Insider TradeINSPInspire Medical Systems4.8552 of 5 stars$129.28-2.4%$211.91+63.9%-2.7%$3.91B$802.80M61.021,246Positive NewsNVSTEnvista3.7235 of 5 stars$19.58-0.5%$20.23+3.3%+23.5%$3.33B$2.51B27.7012,300 Related Companies and Tools Related Companies PEN Alternatives STVN Alternatives GKOS Alternatives IRTC Alternatives NARI Alternatives TMDX Alternatives BLCO Alternatives SLNO Alternatives INSP Alternatives NVST Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LIVN) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LivaNova PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share LivaNova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
